State lawmakers critical of health care costs get feedback from hospitals, insurers
When it comes to who is responsible for the high cost of health care, many of the organizations pointed fingers to different players in the wide-ranging industry.
When it comes to who is responsible for the high cost of health care, many of the organizations pointed fingers to different players in the wide-ranging industry.
The compromise drew quick support from President Joe Biden, who initially pushed for a $22.5 billion package.
The government estimates that between 7.7 and 23 million people may already have long COVID.
Last year, more than 100,000 Americans died of drug overdoses. About two-thirds of the deaths were linked to fentanyl and other synthetic drugs, which can be 50 to 100 times more potent than morphine, heroin or prescription opioids.
The Affordable Insulin Now Act will serve as a political vehicle to rally Democrats and force Republicans who oppose it into uncomfortable votes ahead of the midterms.
The effort, which would finance steps like vaccines, treatments and tests, comes as President Biden and other Democrats have warned the government is running out of money to counter the pandemic.
In its response to lawmakers, IU emphasized the role of public health in health care costs and called on lawmakers to spend more on public health. It pointed to a recent study that ranked Indiana 47th among states in per-person public health funding.
In addition to changing the dashboard’s format, the Indiana Department of Health said it would shrink the its publication schedule from five days a week to three days.
When the end of the COVID-19 pandemic comes, it could create major disruptions for a cumbersome U.S. health care system made more generous, flexible and up-to-date technologically through a raft of temporary emergency measures.
The FDA has also emphasized the need for “regulatory flexibility” when reviewing drugs for fatal diseases like ALS. The panel’s close vote could tip the agency toward an approval, given the lack of options currently available.
On Wednesday, a panel of FDA advisers will take a non-binding vote on whether the drug warrants approval. The meeting is being closely watched as an indicator of the FDA’s approach to experimental drugs with imperfect data and its ability to withstand outside pressure.
The effort to stamp out the chemicals comes in response to an investigation by Consumer Reports that found toxic chemicals in a majority of the food wrappers and packaging from chain restaurants and grocery stores that were tested.
In making their case, executives cited the “persistent and steady decline” of hospitalizations and death rates related to the coronavirus.
Hospitalizations have plummeted 90% since hitting a pandemic high of 3,519 on Jan. 13. COVID patients occupy only 2.9% of Indiana’s intensive care unit beds.
Scores of projects across the United States are being funded with federal coronavirus relief money despite having little to do with combating the pandemic, a review by The Associated Press has found.
One reason the variant has gained ground, scientists say, is that it’s about 30% more contagious than the original omicron.
With an urgent funding request stuck in Congress, a federal agency says it can no longer cover COVID test and treatment bills for uninsured people and will stop taking claims at midnight Tuesday.
The goal is to get patients started on either Pfizer’s Paxlovid tablets or Merck’s molnupiravir capsules within five days of symptoms appearing. But the tight deadline has highlighted several challenges.
Although some fully vaccinated and boosted people came down with mild infections during the omicron surge, the study showed that the vaccines—and especially the booster shot—protected most people from the virus’s worst effects.
U.S. cigarette smoking dropped to a new all-time low in 2020, according to survey data released Thursday by the Centers for Disease Control and Prevention.